| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8361756 | Seminars in Cancer Biology | 2018 | 22 Pages |
Abstract
In this review, we will discuss the current knowledge regarding potential therapeutic targets that might contribute to indirect interference with PAX3-FOXO1 activity in alveolar rhabdomyosarcoma at the different molecular levels and extrapolate these findings to fusion transcription factors in general.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Marco Wachtel, Beat W. Schäfer,